R&D Systems™ Recombinant Human Oncostatin M (OSM) Protein

Catalog No.	Formulation
29-5OM-01MCF	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
29-5OM-01M	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.

Catalog No. 29-5OM-01MCF Supplier R&D Systems™ Supplier No. 295OM01M/CF

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Oncostatin M (OSM) Protein is derived from E. coli. The Recombinant Human Oncostatin M (OSM) Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P13725
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
• Gene ID (Entrez): 5008
• Molecular Weight (g/mol): 22kDa
• Quantity: 1 mg
• Source: E. coli-derived human Oncostatin M/OSM protein Ala26-Arg221
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.01EU per 1μg of the protein by the LAL method.
• Gene Alias: MGC20461, oncostatin M, oncostatin-M
• Gene Symbol: OSM
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 100μg/mL in sterile PBS.
• Purity or Quality Grade: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.